Document text
Principal Investigator: Anthony W.G. Burgett
Organization: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
Fiscal Year: 2024
Award: $17,416
Funding agency: National Institute of Allergy and Infectious Diseases
The current COVID-19 crisis starkly illustrates the need to develop new modalities for the
therapeutic treatment of pathogenic single-stranded RNA (ssRNA) viruses, including against
novel viruses that have yet to emerge. Human oxysterol-binding protein (OSBP) has recently
been determined to be a critical mediator in the replication of a broad spectrum of ssRNA viral
human pathogens, including the enteroviruses, rhinovirus, hepatitis C, Zika virus, Dengue fever
viruses, and coronaviruses. OSBP is an ER-located, non-enzymatic protein reported to function
as an important lipid sensor and lipid transporter in eukaryotic cells. Published research, including
our own recent publications, has established the antiviral activity of structurally-diverse OSBP-
targeting small molecules against multiple RNA pathogenic viruses. These discoveries present
the opportunity for a paradigm shift in antiviral drug development: potentially drug targeting a
human host protein, OSBP, that is required for viral proliferation of a broad-spectrum of RNA
viruses, as opposed to targeting viral proteins present in individual viruses. We have discovered
that transient, low dose treatment with the OSBP-targeting compound OSW-1-compound induces
a longterm, multigenerational repression of OSBP, and the cells with repressed OSBP show a
pronounced inhibition of ssRNA viral replication. Our preliminary results show that the OSW-1-
compound has prophylactic antiviral activity at low nanomolar concentrations against several
ssRNA viruses, including against one coronavirus tested. The longterm repression of OSBP,
triggered by OSW-1, has no effect on cellular division, viability, or morphology.
The purpose of this proposal is to understand the cellular role of OSBP in innate antiviral
response. Our preliminary results show that OSBP: 1) regulates mTORC1 activity, 2) induces
autophagy; 3) slows global protein translation; and 4) activates alternative splicing nonsense-
mediated decay (AS-NMD) process, which is an RNA regulatory process. All of these OSBP-
involved cellular processes would limit ssRNA viral replication individually, but there is little insight
into the organization of these systems to establish a coordinated antiviral response.Our overall
hypothesis is that OSBP serves in a major regulatory role to coordinate a multifaceted innate
antiviral response to ssRNA infection. We propose a complete model of how OSBP senses early-
stage viral infection and then triggers a multisystem response to block viral replication in cells,
including through modulating mTOR1C activity and the AS-NMD system.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Alternate Splicing><Alternative RNA Splicing><Alternative Splicing><Anti-viral Response><Autophagocytosis><Biological><Biology><Breakbone Fever Virus><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 years><COVID19 virus><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Physiology><Cellular Process><Cellular biology><Chemicals><CoV-2><CoV2><Complex><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><DENV><Dengue Virus><Dengue fever virus><Disease><Disorder><Dose><Drug Targeting><Enterovirus><Eukaryotic Cell><Family><Family Picornaviridae><Flavivirus><Foundations><Future><Generations><Goals><Group B Arbovirus><HCV infection><Hepatitis C><Hepatitis C virus infection><Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted><Hepatitus C><Human><Individual><Infection><Innate Immune Response><Lipids><Mediating><Mediator><Membrane><Messenger RNA><Mission><Modality><Modeling><Modern Man><Morphology><NIH><National Institutes of Health><Non-Polyadenylated RNA><Non-sense Mediated Decay><Nonsense-Mediated Decay><OXYB protein><Orthoflavivirus><Pathogenicity><Pathway interactions><Picornaviridae><Picornaviruses><Process><Program Development><Proliferating><Proteins><Public Health><Publications><Publishing><RNA><RNA Gene Products><RNA Viruses><RNA replication><Reporting><Repression><Research><Rhinovirus><Ribonucleic Acid><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scientific Publication><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Subcellular Process><System><Testing><Therapeutic><Therapeutic Intervention><Translations><United States National Institutes of Health><Viral><Viral Activity><Viral Diseases><Viral Function><Viral Gene Products><Viral Gene Proteins><Viral Physiology><Viral Proteins><Virus><Virus Diseases><Virus Replication><Work><Wuhan coronavirus><ZIKV><Zika Virus><anti-viral development><anti-viral drug development><anti-viral immunity><anti-viral therapeutic development><anti-viral therapy development><antiviral development><antiviral drug development><antiviral immunity><antiviral therapeutic development><antiviral therapy development><autophagy><biologic><cell biology><cholesterol-binding protein><corona virus><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><design><designing><developing anti-viral agent><developing anti-viral drug><developing anti-viral therapeutic><developing anti-viral therapy><developing antiviral agent><developing antiviral drug><developing antiviral therapeutic><developing antiviral therapy><disability><drug development><hCoV19><hep C><hepatitis non A non B><human pathogen><infection by hepatitis c virus><insight><intervention therapy><mRNA><membrane structure><mortality><nCoV2><nano-molar><nanomolar><non A, non B hepatitis><non-A, non-B hepatitis><novel virus><oxysterol binding protein><oxysterol receptor><pathogenic virus><pathway><prophylactic><protein function><response><sensor><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><small molecule><social role><therapeutic lead compound><translation><viral infection><viral multiplication><viral pathogen><viral replication><virus infection><virus multiplication><virus pathogen><virus protein><virus-induced disease><zikav>